Pomalidomide (POM), a potent anticancer thalidomide analogue was characterized in terms of cyclodextrin complexation to improve its aqueous solubility and maintain anti-angiogenic activity. The most promising derivatives were selected by phase-solubility studies. From the investigated nine cyclodextrins – differing cavity size, nature substituents, degree substitution charge highest increase ob...